Somatostatin in Polycystic Kidney: a Long-term Three Year Follow up Study

NCT00309283 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Interventions

DRUG: Long-acting somatostatin
OTHER: Saline solution

Sponsor

Mario Negri Institute for Pharmacological Research